Molecular Pathogenesis of Non Muscle-Invasive Bladder Cancer: Implications for Novel Targeted Therapies

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|11|8|623-632

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.11, Iss.8, 2011-11, pp. : 623-632

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression and prognostic significance of Tetranectin in invasive and non-invasive bladder cancer

By Brunner A.   Ensinger C.   Christiansen M.   Heiss S.   Verdorfer I.   Mikuz G.   Tzankov A.  

Virchows Archiv, Vol. 450, Iss. 6, 2007-06 ,pp. : 659-664

Springer Publishing Company

Access to resources Recommend Favorite

Expression of Topoisomerase II Alpha, ki67, and p53 in Primary Non-Muscle-Invasive Urothelial Bladder Carcinoma

By            

Journal of Immunoassay and Immunochemistry, Vol. 35, Iss. 4, 2014-10 ,pp. : 358-367

Taylor & Francis Ltd

Access to resources Recommend Favorite

Editorial (Hot Topic: Biomarkers, Molecular Imaging, and Novel Therapies of Cancer)

By  

Current Molecular Medicine, Vol. 13, Iss. 3, 2013-03 ,pp. : 331-332

Bentham Science Publishers

Access to resources Recommend Favorite

What Makes Y Family Pols Potential Candidates for Molecular Targeted Therapies and Novel Biotechnological Applications

By  

Current Molecular Medicine, Vol. 14, Iss. 1, 2014-01 ,pp. : 96-114

Bentham Science Publishers

Access to resources Recommend Favorite

Non-invasive Atherosclerosis Imaging: Use to Assess Response to Novel or Combination Lipid Therapies

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 557-564

Bentham Science Publishers

Access to resources Recommend Favorite